As Theranos Presses Pause, The Real Healthcare Revolution Is Happening With Artificial …

LONDON — Theranos and 23andMe promised so much. These well-funded startups’ game-changing services — blood tests available at your local Walgreens and health-risk indicators given from a sample of your saliva — seemed to usher in the era of personalized and instant healthcare a few years ago. But with Theranos now pressing pause on the development of its proprietary technology and 23andMe continuing to fight the U.S. Food and Drug Administration to let it provide customers with health risk information, the bright future they heralded seems to be on hold. Until you hear about all the other companies, mostly unknown, offering radical changes in the way the healthcare systems work. They are using techniques like 3D bio-printing, artificial intelligence (AI) and smart drugs to predict diseases before they develop, tailoring treatments to individuals rather than the general population and, theoretically at least, providing…


Link to Full Article: As Theranos Presses Pause, The Real Healthcare Revolution Is Happening With Artificial …